Stacks Image 588
Professor McNicholas has been developing a new treatment option for men with urinary symptoms due to an enlarged prostate (BPH) called the UroLift system. This minimally invasive option opens up the obstructed urinary passage by rearranging and lifting and holding the enlarged prostate tissue out of the way. There is no cutting, heating or removal of prostate tissue. The goal of the treatment with the UroLift system is to relieve symptoms so you can get off drugs and get back to your life or resume your daily activities as soon as possible. In particular, we have developed this to avoid any alteration to sexual function and ejaculation or orgasm. The treatment is usually performed under light sedation or even local anaesthetic and is usually performed as a day case procedure. The UroLift system is being evaluated in regular scientific studies across the world.I published a guide to the method (McNicholas et al European Urology 2013) and have taught it to many surgeons. A rigorous study of Urolift led to FDA approval in the USA in 2013 and was published in the prestigious Journal of Urology in 2014.  NICE approved Urolift as safe for use in the UK NHS in January 2014 and, following a further detailed review, is expected to recommend in September or October 2015 its wider use as safe and effective but also cost saving treatment for mens’ urinary symptoms. 

More information can be found by this link

Further information can be obtained on the Neotract website